What The Coleman Institute for Addiction Medicine does

The Coleman Institute for Addiction Medicine is a privately held, outpatient specialty healthcare provider founded in 1998 by Dr. Peter Coleman and headquartered in Richmond, Virginia. It operates a national network of five outpatient addiction treatment clinics — Richmond VA, Denver CO, Atlanta GA, Tampa FL, and Orange County CA — focused primarily on opioid and alcohol use disorders, with additional programs for benzodiazepines, stimulants, kratom, Suboxone, methadone, buprenorphine, and a long tail of prescription pain medications.

The company's core technology is the proprietary Coleman Method, an accelerated outpatient detoxification protocol that uses non-addictive comfort medications and sedatives to remove opioids or alcohol from patients in 3-8 days without general anesthesia or inpatient stays, followed by Naltrexone therapy — delivered via either a 2-month subcutaneous implant or monthly Vivitrol injection — to suppress cravings for 6-12 months post-detox. The institute reports a 95% program completion rate and has treated more than 8,500 patients over its 25+ year operating history, serving as both a direct-to-consumer provider and an in-network participant with Anthem Blue Cross Blue Shield and Sentara Health Plans; self-pay patients are accepted with financing options.

The business operates a fee-for-service professional services model across its five physical clinics, with revenue tied to completion of acute detox episodes and maintenance Naltrexone regimens. Go-to-market is direct-to-consumer — phone, website, blog/educational content, video and written testimonials, and insurance partnerships — with no enterprise, retail, or third-party distribution channels. Dr. Peter Coleman has retired from clinical practice; current operational leadership includes Andrew Blake (EVP & COO), Jennifer Pius (Director of Clinical Services), Morgan Turnbull (Controller), and Rachel North Allen (Director of Recovery Services). The company remains founder-family owned with no disclosed external investment.

Name

The Coleman Institute for Addiction Medicine

Legal name

The Coleman Institute

Website

https://thecolemaninstitute.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

The Coleman Institute for Addiction Medicine operates a national network of five outpatient addiction treatment clinics specializing in accelerated opioid and alcohol detoxification under its proprietary Coleman Method, serving individual patients across the United States since 1998.

Ownership category

akta.pro rank

Product category

Outpatient Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

akta.pro secondary industries

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF), Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)

Keywords

• Outpatient addiction treatment
• Accelerated opioid detox
• Alcohol detox programs
• Naltrexone therapy
• Medication assisted treatment

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Healthcare Services - Detox Treatment: Fee-for-service healthcare revenue generated from outpatient detoxification treatment services. Patients pay through accepted insurance plans (Anthem Blue Cross Blue Shield, Sentara Health Plans) or self-pay with financing options available.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

The Coleman Institute provides accelerated outpatient detoxification and relapse-prevention services for opioid, alcohol, benzodiazepine, stimulant, kratom, and prescription pain medication dependencies, delivered via its proprietary Coleman Method in 3-8 days at owned clinics. Treatment is followed by Naltrexone Therapy (implant or Vivitrol injection) for 6-12 months of craving reduction. The institute treats individual patients directly, accepting insurance (Anthem Blue Cross Blue Shield, Sentara) and self-pay with financing.

Product overview

The Coleman Institute for Addiction Medicine offers a comprehensive portfolio of outpatient addiction treatment services built around its proprietary Coleman Method. The core offering consists of accelerated detox programs for opioids (heroin, fentanyl, oxycodone, hydrocodone, Percocet, Vicodin, Roxicodone, Tramadol, Ultram, Opana), alcohol, prescription drugs, pain medications, Suboxone, Methadone, Buprenorphine, Kratom, Benzodiazepines, and stimulants. These detox programs are designed to complete in 3-8 days on an outpatient basis using non-addictive comfort medications. Post-detox, patients receive Naltrexone Therapy (via implant or Vivitrol injection) for 6-12 months to reduce cravings and prevent relapse. The company operates 5 locations nationwide (Richmond VA, Denver CO, Tampa FL, Atlanta GA, Orange County CA) and has treated over 8,500 patients since 1998 with a 95% completion rate.

Differentiator

Problem solved

Functional benefit

Brands

• The Coleman Method: A proprietary detoxification method developed by Dr. Peter Coleman for accelerated outpatient detox from opiates and alcohol, with a 95% completion rate.

Products and services

• Accelerated Opioid Detox Outpatient detox program using the Coleman Method that removes opioids from the brain in 3 days, minimizing withdrawal discomfort through non-addictive medications and sedatives. Offered to individuals dependent on opioid-class substances.
• Alcohol Detox Outpatient detox program that safely and comfortably removes alcohol from the body in as few as 3 days, with vitamin replenishment and support for brain recovery. For individuals with alcohol use disorder.
• Heroin Detox Five-day outpatient accelerated detox program that removes heroin from opioid receptors in the brain using non-addictive drugs and sedatives. For individuals dependent on heroin.
• Fentanyl Detox Accelerated outpatient detox that removes fentanyl from the body in as little as 5 days without painful withdrawal symptoms or hospital stays. For individuals dependent on fentanyl.
• Prescription Drug Detox Outpatient detox program for dependency on prescription opioid medications, completed in 3-8 days using non-addictive comfort medications.
• Pain Medication Detox Medication-assisted treatment (MAT) program that eliminates addictive pain medications from the body on an outpatient basis in 3-8 days. For individuals dependent on prescribed opioid pain medications.
• Suboxone Detox Eight-day outpatient detox program to free patients from Suboxone (buprenorphine) dependency using non-addictive drugs and sedatives. For patients on Suboxone maintenance who want to be opioid-free.
• Methadone Detox Accelerated outpatient methadone detox that can handle doses up to 300mg, completed within 8 days without the discomfort of self-detoxing. For patients on methadone maintenance who want to be opioid-free.
• Kratom Detox Accelerated outpatient detox program to remove Kratom from the body in as few as 3 days with no general anesthesia or hospital stays required. For individuals dependent on kratom.
• Benzo Detox Rapid benzodiazepine detox program to safely remove benzos from the body with medical supervision and support. For individuals dependent on benzodiazepines.
• Stimulant Detox Outpatient detox program for stimulant addictions including cocaine and methamphetamine. For individuals dependent on stimulant drugs.
• Buprenorphine Detox Eight-day outpatient detox program to remove buprenorphine from the body using the Coleman Method, completed in as few as 8 days. For patients on buprenorphine maintenance who want to be opioid-free.
• Oxycodone Detox Accelerated outpatient detox that removes oxycodone from the body in as few as 3 days with no general anesthesia or hospital stays required. For individuals dependent on oxycodone.
• Percocet Detox Accelerated outpatient detox to remove Percocet from the brain in approximately 3 days using the Coleman Method. For individuals dependent on Percocet.
• Hydrocodone Detox Accelerated outpatient detox to remove hydrocodone from the brain in about 3 days, restoring normal endorphin production. For individuals dependent on hydrocodone.
• Vicodin Detox Accelerated outpatient detox program to remove Vicodin from the body in as few as 3 days, restoring natural endorphin production. For individuals dependent on Vicodin.
• Tramadol Detox Accelerated outpatient detox to remove Tramadol from opioid receptors in as few as 5 days using the Coleman Method. For individuals dependent on tramadol.
• Ultram Detox Accelerated outpatient detox to remove Ultram (tramadol) from the body in as few as 5 days with non-addictive comfort medications. For individuals dependent on Ultram.
• Opana Detox Accelerated outpatient detox to remove Opana from the body in as few as 3 days using non-addictive drugs and sedatives. For individuals dependent on Opana.
• Roxicodone Detox Accelerated outpatient detox to remove Roxicodone from the body in as few as 3 days without painful withdrawal symptoms. For individuals dependent on Roxicodone.
• Ultra-Rapid Detoxification Detoxification method where opioids are gently removed from the brain over 6-8 hours while the patient relaxes in a comfortable bed, followed by long-acting Naltrexone administration. For patients seeking the fastest possible outpatient opioid detox.
• Naltrexone Therapy Medication-assisted treatment using non-addictive opioid blocker Naltrexone (via implant or Vivitrol injection) to reduce cravings and prevent relapse for 12 months post-detox. Delivered as a follow-on to Coleman Method detox programs.
• Naltrexone Implant Small pellet inserted under the skin that slowly releases Naltrexone over 8 weeks, providing consistent medication delivery to block cravings. A delivery format within Naltrexone Therapy.
• Vivitrol Injections FDA-approved extended-release injectable Naltrexone formulation that provides one month of continuous medication with a single dose. A delivery format within Naltrexone Therapy.
• The Coleman Method Proprietary treatment approach developed by Dr. Peter Coleman in 1998 for accelerated outpatient detox, using non-addictive comfort medications and Naltrexone to minimize withdrawal symptoms and achieve a 95% completion rate. Underlies the institute's full portfolio of detox services.

Quantifiable outcome

• 95% of patients successfully complete their detox
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Anthem Blue Cross Blue ShieldcoreOthersAccepted insurance provider. Patients with Anthem Blue Cross Blue Shield coverage can use their health insurance to cover treatment costs at The Coleman Institute.
• Sentara Health PlanscoreOthersAccepted insurance provider. Patients with Sentara Health Plans coverage can use their health insurance to cover treatment costs at The Coleman Institute.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CleanSlate Outpatient Addiction Medicine: CleanSlate operates a national network of outpatient addiction medicine clinics offering MAT and detox services. Closely comparable to Coleman Institute in operating model (multi-site outpatient clinics, opioid/alcohol focus, insurance-based revenue).
• BrightView Health: BrightView is a multi-state outpatient addiction treatment provider delivering MAT, detox, and counseling. Direct peer given shared outpatient SUD model, multiple clinic locations, and emphasis on medication-assisted opioid treatment.
• The Recovery Village: The Recovery Village (part of Advanced Recovery Systems) runs a network of rehab and detox centers across multiple states. Comparable as multi-location SUD treatment operator, though more weighted toward inpatient/residential care than Coleman's outpatient focus.
• Ideal Option: Ideal Option is a multi-site outpatient addiction medicine provider specializing in MAT for opioid and stimulant use disorders. Direct peer given shared outpatient, multi-clinic, MAT-led model serving similar patient segments.

Emerging players

• Bicycle Health: Bicycle Health is a virtual MAT provider for opioid use disorder, serving patients across many U.S. states via telemedicine. Comparable target population and treatment category but competing via telehealth rather than in-person accelerated detox.
• Workit Health: Workit Health delivers online SUD treatment including MAT, therapy, and recovery support. Same patient population and category as Coleman but with a telehealth-first model and broader chronic-care framework.
• Ophelia: Ophelia provides telehealth-based opioid use disorder treatment, including Suboxone prescriptions and ongoing support. Comparable patient segment (opioid addiction) but emerging as a lower-cost, at-home alternative to Coleman's in-person accelerated detox.

Broad incumbents

• Hazelden Betty Ford Foundation: Hazelden Betty Ford is a large, established nonprofit addiction treatment provider with residential, outpatient, and recovery services. Comparable in category and patient population, but at much broader scale and primarily inpatient-focused, with outpatient as one arm of a wider portfolio.
• American Addiction Centers: American Addiction Centers operates multiple treatment facilities across the U.S. offering detox, residential, and outpatient services for SUD. Broad incumbent competing in the same category with a much larger, multi-modality footprint.
• Behavioral Health Group (BHG): BHG operates one of the largest networks of outpatient opioid treatment programs in the U.S., offering MAT and counseling. Comparable target market and category; broader incumbent with significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/colemanrecovery
• Facebookfacebook.com/thecolemaninstitute
• LinkedInlinkedin.com/company/the-coleman-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Coleman Institute for Addiction Medicine